ZA933178B - Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration - Google Patents

Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration

Info

Publication number
ZA933178B
ZA933178B ZA933178A ZA933178A ZA933178B ZA 933178 B ZA933178 B ZA 933178B ZA 933178 A ZA933178 A ZA 933178A ZA 933178 A ZA933178 A ZA 933178A ZA 933178 B ZA933178 B ZA 933178B
Authority
ZA
South Africa
Prior art keywords
pct
rectal administration
pharmaceutical compositions
receptor agonists
sec
Prior art date
Application number
ZA933178A
Other languages
English (en)
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of ZA933178B publication Critical patent/ZA933178B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZA933178A 1992-05-07 1993-05-06 Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration ZA933178B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (1)

Publication Number Publication Date
ZA933178B true ZA933178B (en) 1994-01-10

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA933178A ZA933178B (en) 1992-05-07 1993-05-06 Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration

Country Status (33)

Country Link
US (1) US5705506A (pt)
EP (1) EP0639072B1 (pt)
JP (1) JPH07506570A (pt)
KR (1) KR100253111B1 (pt)
AT (1) ATE163850T1 (pt)
AU (1) AU670083B2 (pt)
BE (1) BE1007024A5 (pt)
BG (1) BG62120B1 (pt)
BR (1) BR1100108A (pt)
CA (1) CA2135179C (pt)
CH (1) CH685920A5 (pt)
CY (1) CY2039B1 (pt)
CZ (1) CZ283512B6 (pt)
DE (1) DE69317418T2 (pt)
ES (1) ES2113533T3 (pt)
FR (1) FR2690847B1 (pt)
GB (2) GB9209882D0 (pt)
GR (1) GR3026584T3 (pt)
HK (1) HK95697A (pt)
HU (2) HU227338B1 (pt)
IE (1) IE75203B1 (pt)
IL (1) IL105468A (pt)
IT (1) IT1261471B (pt)
NO (1) NO306700B1 (pt)
NZ (1) NZ252132A (pt)
OA (1) OA10109A (pt)
RO (1) RO112993B1 (pt)
RU (1) RU2118527C1 (pt)
SG (1) SG46649A1 (pt)
TW (1) TW231970B (pt)
UA (1) UA37206C2 (pt)
WO (1) WO1993021916A1 (pt)
ZA (1) ZA933178B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
ATE464900T1 (de) * 1998-03-26 2010-05-15 Astellas Pharma Inc Retardpräparat mit makroliden wie tacrolimus
US7704958B1 (en) * 1999-03-05 2010-04-27 Bio Holding, Inc. Methods and compositions for inhibiting apoptosis using serine protease inhibitors
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ,インコーポレイテッド 医薬組成物
EP2240022B1 (en) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
CN103402514B (zh) 2010-10-15 2016-01-13 康特拉医药公司 用于治疗运动障碍的血清素受体激动剂组合物
JP6216768B2 (ja) 2012-04-18 2017-10-18 コンテラ ファーマ アンパルトセルスカブContera Pharma Aps 運動障害の管理の改善に適した経口投与可能な医薬製剤
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ,インコーポレイテッド 医薬組成物
US11975104B2 (en) 2016-07-11 2024-05-07 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2083463B (en) * 1980-08-12 1984-05-10 Glaxo Group Ltd Heterocyclic compounds
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
AU584142B2 (en) * 1984-12-04 1989-05-18 Glaxo Group Limited Indole derivatives
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
KR0131327B1 (en) * 1987-08-13 1998-04-17 Glaxo Group Ltd Indole derivatives
HU219974B (hu) * 1990-06-07 2001-10-28 Astrazeneca Ab, Heterociklusos csoporttal helyettesített indolszármazék, előállítása és a vegyületet hatóanyagként tartalmazó gyógyszerkészítmények

Also Published As

Publication number Publication date
NO306700B1 (no) 1999-12-13
IL105468A (en) 1998-09-24
BR1100108A (pt) 1999-12-07
NO944214L (no) 1994-11-07
GB9209882D0 (en) 1992-06-24
EP0639072B1 (en) 1998-03-11
GB2266665A (en) 1993-11-10
IE930339A1 (en) 1993-11-17
OA10109A (en) 1996-12-18
CH685920A5 (fr) 1995-11-15
CY2039B1 (en) 1998-04-30
IE75203B1 (en) 1997-08-27
RU2118527C1 (ru) 1998-09-10
GR3026584T3 (en) 1998-07-31
ITRM930286A0 (it) 1993-05-06
CA2135179A1 (en) 1993-11-11
KR100253111B1 (en) 2000-07-01
ATE163850T1 (de) 1998-03-15
IL105468A0 (en) 1993-08-18
SG46649A1 (en) 1998-02-20
US5705506A (en) 1998-01-06
GB9309209D0 (en) 1993-06-16
TW231970B (pt) 1994-10-11
HK95697A (en) 1997-08-08
CZ283512B6 (cs) 1998-04-15
AU670083B2 (en) 1996-07-04
BE1007024A5 (fr) 1995-02-21
HU211638A9 (en) 1995-12-28
NO944214D0 (no) 1994-11-04
ES2113533T3 (es) 1998-05-01
FR2690847A1 (fr) 1993-11-12
AU4064093A (en) 1993-11-29
HU227338B1 (en) 2011-04-28
NZ252132A (en) 1996-09-25
RO112993B1 (ro) 1998-03-30
DE69317418T2 (de) 1998-07-30
BG62120B1 (bg) 1999-03-31
GB2266665B (en) 1996-05-22
IT1261471B (it) 1996-05-23
ITRM930286A1 (it) 1994-11-06
HUT71418A (en) 1995-11-28
DE69317418D1 (de) 1998-04-16
CZ272394A3 (en) 1995-10-18
JPH07506570A (ja) 1995-07-20
FR2690847B1 (fr) 1995-06-09
EP0639072A1 (en) 1995-02-22
CA2135179C (en) 2000-12-05
UA37206C2 (uk) 2001-05-15
WO1993021916A1 (en) 1993-11-11
BG99167A (bg) 1995-06-30

Similar Documents

Publication Publication Date Title
AU6750996A (en) Oral fast-dissolving compositions for dopamine agonists
ATE331726T1 (de) Adenine-derivate
AP2001002129A0 (en) 5HT1 receptor agonists and metoclopramide for the treatment of migrane.
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
MX9702865A (es) Agentes estrogenicos.
MY136249A (en) Phenylethanolamine compounds as anti-obesity agents
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
ZA933178B (en) Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration
YU2603A (sh) Nova kombinacija (5ht2) agonista i (5ht6) antagonista serotonina kao farmaceutska kombinacija
IL114600A (en) Thiazole and thiadiazole compounds their preparation and pharmaceutical compositions containing them
IL114598A (en) Triazole compounds their preparation and pharmaceutical compositions containing them
GR3022615T3 (en) Pharmaceutical compositions based on ebastime or analogues thereof.
WO2000000198A8 (en) Piperidine derivatives having effects on serotonin related systems
EP1064966A3 (en) Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
GR3036195T3 (en) Novel compounds
BG102229A (en) Endothelium receptor antagonists
EP1064948A3 (en) Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
EP1051994A3 (en) 5HT1 receptor agonists and a COX-2 inhibitor for the treatment of migraine